Avodart (dutasteride), a new drug for benign prostatic hyperplasia (BPH)

January 2004

GlaxoSmithKline is now marketing Avodart (dutasteride), a new drug for benign prostatic hyperplasia (BPH).

It's a 5-alpha reductase inhibitor...similar to Proscar.

Blocking this enzyme reduces the production of dihydrotestosterone which stimulates the growth of prostate cells.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

attention being focused on preventing and treating the flu
Men's Health Avodart (dutasteride), a new drug for benign prostatic hyperplasia (BPH)
Men's Health some medications can worsen urinary symptoms
Reyataz, which will help simplify HIV drug regimens
A simple new technique might help patients who get nosebleeds from nasal steroids
Women's Health Climara Pro, a new COMBINATION estrogen and progestin patch for relieving menopausal symptoms
Women's Health big push to increase access to emergency contraceptives
Supplements ThyroSafe, a tablet form of potassium iodide
Paxil CR, a new controlled-release version of paroxetine
latest guidelines on treating motion sickness
Dermatology Stieprox, a new antifungal shampoo for dandruff
Obesity & Weight Loss what works for weight loss
Hematology & Oncology potential interaction between tamoxifen and paroxetine (Paxil)
Cardiology Spironolactone will be used more for hypertension